Evidence map›Paper›PMID 19790069›Full record

ArticleArthritis and rheumatism2009

The impact of anterior cruciate ligament injury on lubricin metabolism and the effect of inhibiting tumor necrosis factor alpha on chondroprotection in an animal model.

K A Elsaid, J T Machan, K Waller, B C Fleming, G D Jay

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Assessment of osteoarthritis functional outcomes and intra-articular injection volume in the rat anterior cruciate ligament transection model.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022
    Article
  14. Article
  15. Article
  16. The synthetic artificial stem cell (SASC): Shifting the paradigm of cell therapy in regenerative engineering.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

K A ElsaidBrown University, Providence, Rhode Island, USA.
J T Machan
K Waller
B C Fleming
G D Jay
Brown University · USLifespan · USRhode Island Hospital · US

Funding

RI COBRE: REGULATION OF GROWTH PLATE DEVELOPMENT BYNUCLEAR/CYTOPLASMIC FACTORSP20RR024484 · NCRR · RHODE ISLAND HOSPITAL · PI BOSTOM, ANDREW G. · 2007 to 2011
$11.9M
Lubricin Function in Articulating JointsR01AR050180 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI JAY, GREGORY D., WARMAN, MATTHEW L · 2003 to 2012
$4.5M
Restitution of Lubrication in ACL Deficient Joints Preventing WearR21AR055937 · NIAMS · RHODE ISLAND HOSPITAL · PI JAY, GREGORY D. · 2008 to 2009
$365k
Howard Hughes Medical InstituteNCRR NIH HHS P20 RR024484NCRR NIH HHS P20-RR-024484-01NIAMS NIH HHS R01 AR050180NIAMS NIH HHS R01-AR-050180NIAMS NIH HHS R21 AR055937NIAMS NIH HHS R21-AR-055937
6 · The paper itself

Abstract

objectiveTo examine the effects of anterior cruciate ligament transection (ACLT) in a rat model on lubricin metabolism and its relationship to markers of inflammation and cartilage damage, and to determine whether blocking the metabolic effects of tumor necrosis factor alpha (TNFalpha) by etanercept increases the chondroprotection provided by lubricin.

methodsUnilateral ACLT was performed in Lewis rats. Levels of lubricin, TNFalpha, interleukin-1beta (IL-1beta), and sulfated glycosaminoglycans (sGAG) in synovial fluid (SF) lavage specimens and synovial tissue lubricin gene expression were evaluated at 1 week and 4 weeks following ACLT. Histologic evaluation of articular cartilage included staining with lubricin-specific monoclonal antibody 9G3 and Safranin O. The percentage of lubricin staining on the surface of articular cartilage in weight-bearing areas was estimated by digital imaging. Blocking of TNFalpha was performed using etanercept, which was administered subcutaneously at a dose of 0.5 mg/kg around the ACL-transected joints, using different dosing strategies. The ACL-transected and contralateral joints of these rats were harvested 4 weeks following surgery.

resultsFour weeks following ACLT, SF lubricin concentrations and the percentage of cartilage surface lubricin staining were significantly lower in the injured joints compared with the contralateral joints. A significant decrease in synovial tissue lubricin gene expression was associated with elevated TNFalpha and IL-1beta concentrations in SF lavage samples. With all of the etanercept treatment strategies, blocking of TNFalpha significantly increased the amount of lubricin bound to cartilage, coupled with a significant decrease in sGAG release. However, changes in the concentrations of lubricin in SF were variable.

conclusionBlocking TNFalpha resulted in a chondroprotective effect, exemplified by increased lubricin deposition on articular cartilage and a decrease in sGAG release from articular cartilage in an animal model of posttraumatic arthritis.

Indexed as

Anterior Cruciate Ligament InjuriesAnimalsAnti-Inflammatory Agents, Non-SteroidalArthritisChondrocytesDisease Models, AnimalEtanerceptGlycoproteinsGlycosaminoglycansImmunoglobulin GInterleukin-1betaMaleProteoglycan 4RatsRats, Inbred LewReceptors, Tumor Necrosis FactorAnti-Inflammatory Agents, Non-SteroidalEtanerceptGlycoproteinsGlycosaminoglycansImmunoglobulin GInterleukin-1betaProteoglycan 4Receptors, Tumor Necrosis FactorTumor Necrosis Factor-alpha

Identifiers

PMID19790069
PMCPMC2800051
OpenAlexW2042694177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.